2,539
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Mediating role of C-reactive protein in associations between pre-pregnancy BMI and adverse maternal and neonatal outcomes: the ABCD-study cohort

ORCID Icon, , , , &
Pages 2867-2875 | Received 15 Apr 2020, Accepted 05 Aug 2020, Published online: 24 Aug 2020

References

  • Gaillard R, Steegers EA, Hofman A, et al. Associations of maternal obesity with blood pressure and the risks of gestational hypertensive disorders. The Generation R Study. J Hypertens. 2011;29:937–944.
  • Savitri AI, Zuithoff P, Browne JL, et al. Does pre-pregnancy BMI determine blood pressure during pregnancy? A prospective cohort study. BMJ Open. 2016;6(8):e011626.
  • Nohr EA, Bech BH, Vaeth M, et al. Obesity, gestational weight gain and preterm birth: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol. 2007;21(1):5–14.
  • Cnattingius S, Villamor E, Johansson S, et al. Maternal obesity and risk of preterm delivery. JAMA. 2013;309(22):2362.
  • Savitz DA, Danilack VA, Elston B, et al. Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery. Am J Epidemiol. 2014;180(1):41–44.
  • Villamor E, Tedroff K, Peterson M, et al. Association between maternal body mass index in early pregnancy and incidence of cerebral palsy. JAMA. 2017;317(9):925–936.
  • Chen YH, Li L, Chen W, et al. Pre-pregnancy underweight and obesity are positively associated with small-for-gestational-age infants in a Chinese population. Sci Rep. 2019;9(1):9.
  • Shin D, Song WO. Prepregnancy body mass index is an independent risk factor for gestational hypertension, gestational diabetes, preterm labor, and small- and large-for-gestational-age infants. J Matern Neonatal Med. 2015;28(14):1679–1686.
  • Lauring JR, Gupta M, Kunselman AR, et al. The Journal of Maternal-Fetal & Neonatal Medicine Identification of small for gestational age by population-based and customized growth charts in newborns of obese and normal-weight primiparous women Identification of small for gestational age by population-based and customized growth charts in newborns of obese and normal-weight primiparous women. J Matern Fetal Neonatal Med. 2016;29:1–3574.
  • Yao R, Park BY, Caughey AB. The effects of maternal obesity on perinatal outcomes among those born small for gestational age. J Matern Neonatal Med. 2017;30(12):1417–1422.
  • Denison FC, Roberts KA, Barr SM, et al. Obesity, pregnancy, inflammation, and vascular function. Reproduction. 2010;140(3):373–385.
  • Sacks GP, Seyani L, Lavery S, et al. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod. 2004;19(4):1025–1030.
  • Huda SS, Jordan F, Bray J, et al. Visceral adipose tissue activated macrophage content and inflammatory adipokine secretion is higher in pre-eclampsia than in healthy pregnancy. Clin Sci. 2017;131(13):1529–1540.
  • Fontana L, Eagon JC, Trujillo ME, et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56(4):1010–1013.
  • Schmatz M, Madan J, Marino T, et al. Maternal obesity: the interplay between inflammation, mother and fetus. J Perinatol. 2010;30(7):441–446.
  • McDade TW, Borja JB, Largado F, et al. Adiposity and chronic inflammation in young women predict inflammation during normal pregnancy in the Philippines. J Nutr. 2016;146(2):353–357.
  • de Jonge LL, Steegers EAP, Ernst GDS, et al. C-reactive protein levels, blood pressure and the risks of gestational hypertensive complications. J Hypertens. 2011;29(12):2413–2421.
  • Qiu C, Luthy DA, Zhang C, et al. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens. 2004;17(2):154–160.
  • Rebelo F, Schlüssel MM, Vaz JS, et al. C-reactive protein and later preeclampsia: systematic review and meta-analysis taking into account the weight status. J Hypertens. 2013;31(1):16–26.
  • Lohsoonthorn V, Qiu C, Williams MA. Maternal serum C-reactive protein concentrations in early pregnancy and subsequent risk of preterm delivery. Clin Biochem. 2007;40(5–6):330–335.
  • Bullen BL, Jones NM, Holzman CB, et al. C-reactive protein and preterm delivery: clues from placental findings and maternal weight. Reprod Sci. 2013;20(6):715–722.
  • Ernst GDS, De Jonge LL, Hofman A, et al. C-reactive protein levels in early pregnancy, fetal growth patterns, and the risk for neonatal complications: the Generation R Study. Am J Obstet Gynecol. 2011;205:132.e1-12.
  • Bernardes TP, Zwertbroek EF, Broekhuijsen K, et al. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis. Ultrasound Obstet Gynecol. 2019;53(4):443–453.
  • Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol. 2010;116(2, Part 1):393–401.
  • Bodnar LM, Ness RB, Harger GF, et al. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol. 2005;162(12):1198–1206.
  • Van Eijsden M, Vrijkotte TG, Gemke RJ, et al. Cohort profile: the Amsterdam born children and their development (ABCD) study. Int J Epidemiol. 2011;40(5):1176–1186.
  • Méray N, Reitsma JB, Ravelli ACJ, et al. Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number. J Clin Epidemiol. 2007;60(9):883–883.e11.
  • Vrijkotte TGM, Krukziener N, Hutten BA, et al. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study. J Clin Endocrinol Metab. 2012;97(11):3917–3925.
  • Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310.
  • Visser GHA, Eilers PHC, Elferink-Stinkens PM, et al. New Dutch reference curves for birthweight by gestational age. Early Hum Dev. 2009;85(12):737–744.
  • de Oliveira LC, Franco-Sena AB, Rebelo F, et al. Factors associated with maternal serum C-reactive protein throughout pregnancy: a longitudinal study in women of Rio de Janeiro, Brazil. Nutrition. 2015;31(9):1103–1108.
  • Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36(4):717–731.
  • VanderWeele TJ, Vansteelandt S. Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol. 2010;172(12):1339–1348.
  • MacKinnon DP, Krull JL, Lockwood CM. Equivalence of the mediation, confounding and suppression effect. Prev Sci. 2000;1(4):173–181.
  • Catov JM, Bodnar LM, Ness RB, et al. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol. 2007;166(11):1312–1319.
  • Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet (London, England). 2008;371(9606):75–84.
  • Tjoa ML, Van Vugt JMG, Go ATJJ, et al. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol. 2003;59(1):29–37.
  • Patel S, Lawlor DA, Callaway M, et al. Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease. BMC Pediatr. 2016;16(1):47.
  • Bahadoer S, Gaillard R, Felix JF, et al. Ethnic disparities in maternal obesity and weight gain during pregnancy. The Generation R Study. Eur J Obstet Gynecol Reprod Biol. 2015;193:51–60.
  • Fisher SC, Kim SY, Sharma AJ, et al. Is obesity still increasing among pregnant women? Prepregnancy obesity trends in 20 states, 2003–2009. Prev Med (Baltim). 2013;56(6):372–378.
  • Djurovic S, Clausen T, Wergeland R, et al. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG. 2002;109(7):759–764.
  • Taylor BD, Ness RB, Klebanoff MA, et al. First and second trimester immune biomarkers in preeclamptic and normotensive women. Pregnancy Hypertens. 2016;6(4):388–393.
  • Zavalza-Gómez AB. Obesity and oxidative stress: a direct link to preeclampsia? Arch Gynecol Obstet. 2011;283(3):415–422.
  • Shin D, Chung H, Weatherspoon L, et al. Validity of prepregnancy weight status estimated from self-reported height and weight. Matern Child Health J. 2014;18(7):1667–1674.
  • Bannon AL, Waring ME, Leung K, et al. Comparison of self-reported and measured pre-pregnancy weight: implications for gestational weight gain counseling. Matern Child Health J. 2017;21(7):1469–1478.
  • Meier-Ewert HK, Ridker PM, Rifai N, et al. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem. 2001;47(3):426–430.
  • Ray JG, De Souza LR, Park AL, et al. Preeclampsia and preterm birth associated with visceral adiposity in early pregnancy. J Obstet Gynaecol Can. 2017;39(2):78–81.
  • Ferguson KK, Meeker JD, McElrath TF, et al. Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies. Am J Obstet Gynecol. 2017;216(5):527.e1–527–e9.